6505--Lenalidomide (Revlimid) Dose-Brand name only
ID: 36C25226Q0072Type: Sources Sought
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF252-NETWORK CONTRACT OFFICE 12 (36C252)MILWAUKEE, WI, 53214, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/workspace/contract/opp/5e18a5e8cc0f4b78bdcd6273546e60fe/view
Timeline
    Description

    The Department of Veterans Affairs is seeking qualified suppliers to provide Lenalidomide, a pharmaceutical product, for the Oscar G. Johnson VA Medical Center located in Iron Mountain, MI. This procurement will be conducted through a Brand Name or Equal Request for Quotation (RFQ) under firm-fixed price terms, following FAR Part 13 Simplified Acquisition Procedures. Lenalidomide is crucial for treating certain conditions, making this procurement significant for patient care within the VA system. Interested offerors must submit an itemized quote along with sufficient technical documentation via email to arneil.genus@va.gov by 3 p.m. Central on December 1, 2025, as telephone inquiries will not be accepted.

    Point(s) of Contact
    Arneil GenusContract Specialist
    Email only
    arneil.genus@va.gov
    Files
    Title
    Posted
    36C25226Q0072_1.docx
    The Department of Veterans Affairs (VA), Oscar G. Johnson VA Medical Center, has issued a Sources Sought Notice for Lenalidomide (Revlimid) Dose-Brand name only. This Request for Information (RFI) is for planning purposes, seeking to identify interested and capable Small Businesses (including SDVOSB/VOSB) and Other Than Small Businesses for providing this oral immunomodulatory medication used to treat blood cancers. The VA requires Lenalidomide in various capsule strengths for a one-time purchase/delivery agreement with a 12-month performance period. Responders must be registered in SAM.gov and provide capabilities statements, business size status, manufacturing/distributor information, compliance with regulations like the Buy American Act and Non-Manufacturer Rule, lead times, FDA clearance, and pricing for market research. Responses are due by November 3, 2025, 3:00 PM CST, via email to arneil.genus@va.gov.
    36C25226Q0072_2.docx
    The VA Great Lakes Acquisition Center intends to issue a Brand Name or Equal RFQ 36C25226Q0072 for Lenalidomide, a pharmaceutical, for the Oscar G. Johnson VA Medical Center in Iron Mountain, MI. This firm-fixed price solicitation, conducted under FAR Part 13 Simplified Acquisition Procedures, has a NAICS Code of 325412 and a Product Service Code of 6505. Offerors must submit an itemized quote and sufficient technical supporting documentation via email to arneil.genus@va.gov by 3 p.m. Central, December 1, 2025. Telephone calls will not be accepted. The solicitation number is 36C25226Q0072, and the contracting office is located at 115 South 84th Street, Suite 101, Milwaukee, WI 53214-1476.
    S02_RFQ 36C25226Q0072_Lenalidomide.Revlimid_closed NLT 11.21.25, 3 PM CST.docx
    The Department of Veterans Affairs (VA), specifically the Oscar G. Johnson VA Medical Center, Pharmacy Service Department, is soliciting proposals for the purchase and delivery of Lenalidomide/Revlimid medication. This is a restricted distribution program under the Lenalidomide Risk Evaluation and Mitigation Strategy (REMS), requiring certified pharmacies and enrolled patients. The solicitation is a Request for Proposal (RFP) for a brand name or equal product, with an award based on the lowest price technically acceptable offer. The contract will be for a 12-month period, with delivery to the Oscar G. Johnson VA Hospital in Iron Mountain, MI. The selected contractor, referred to as "Vendor-TBD," will be responsible for dispensing the medication, coordinating with the VA pharmacy, and ensuring timely delivery to patients or the VA pharmacy. Invoices must be submitted electronically through the Tungsten Network. The contract outlines specific clauses regarding payment, delivery, and adherence to federal acquisition regulations.
    Similar Opportunities
    6505--Lenalidomide - Brand Name or Generic
    Buyer not available
    The Department of Veterans Affairs is seeking information from vendors regarding the procurement of Lenalidomide, either in brand name or generic form, for the West Texas VA Health Care System. This sources sought notice aims to gather details on various dosages of Lenalidomide capsules to inform future procurement strategies, potentially leading to either competitive bidding or sole source purchases. Lenalidomide is a critical pharmaceutical used in the treatment of certain cancers and conditions, making this procurement essential for patient care within the VA system. Interested vendors must submit a capability statement by December 5, 2025, at 5:00 PM CST, including their technical capabilities and company information, to Contracting Specialist Matt Lee at matthew.lee5@va.gov or by phone at 210-393-9281.
    VISN 21 Lenalidomide Capsules Multiple Strengths (Generic)
    Buyer not available
    The Department of Veterans Affairs (VA) is conducting a Sources Sought notice to identify vendors capable of supplying Lenalidomide Capsules in multiple strengths, specifically for VISN 21, which includes locations in California, Hawaii, Nevada, and Manila, Philippines. The contractor must be a Certified Lenalidomide REMS Pharmacy, licensed in the applicable states, and comply with all relevant federal, state, and VA regulations, including USP <800> for hazardous drugs. This procurement is critical as Lenalidomide is an oral anti-cancer medication, and the contract will span five one-year ordering periods from March 1, 2026, to February 28, 2031, requiring timely and compliant delivery of FDA-approved products. Interested vendors should submit their capability statements and relevant information to David J. Alvarez at david.alvarez4@va.gov by 10:00 AM Pacific Time on December 10, 2025.
    6505--Dimethyl Fumarate Capsules
    Buyer not available
    The Department of Veterans Affairs (VA) is seeking offers for the procurement of Dimethyl Fumarate Capsules (120MG and 240MG delayed-release) through solicitation 36E79726R0003. This contract aims to establish a reliable supply source for these pharmaceutical products to support VA, Department of Defense (DoD), Indian Health Service (IHS), and Bureau of Prisons (BOP) facilities, with a contract structure that includes a one-year base ordering period and four one-year options. The products are critical for treating specific medical conditions, and offerors must comply with stringent requirements, including FDA regulations, Drug Supply Chain Security Act (DSCSA) compliance, and the provision of unique National Drug Codes (NDCs). The deadline for submitting offers has been extended to December 9, 2025, at 2:30 PM CST, and interested parties can contact Contract Specialist Kenneth Lay at Kenneth.Lay@va.gov for further information.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    Dimethyl Fumarate DR Presolicitation
    Buyer not available
    The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Dimethyl Fumarate DR capsules, specifically 120MG capsules in 14 count bottles and 240MG capsules in 60 count bottles. This procurement aims to establish a reliable national supply source for these pharmaceutical products, which are essential for Department of Defense (DoD) customers through the DLA prime vendor program. The contract will be a firm-fixed price, requirements type contract with a one-year base period and four one-year options, emphasizing compliance with federal regulations and efficient distribution of pharmaceuticals for military healthcare. Interested parties should contact Kevin Rafferty at kevin.rafferty@dla.mil or 215-737-0907 for further inquiries, and the projected solicitation date is February 2021, with an amendment extending the offer submission deadline to October 14, 2021, at 3:00 PM EST.
    6505--Zonisamide Capsules
    Buyer not available
    The Department of Veterans Affairs (VA) intends to issue a Request for Proposal (RFP) for the unrestricted procurement of Zonisamide Capsules, which will serve various federal entities including the Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The contract will be awarded to a single offeror capable of providing an uninterrupted supply of the specified medications, with a contract period of one year and four optional one-year extensions. The procurement is critical for ensuring the availability of these pharmaceutical products, which are essential for patient care within the VA and other federal health facilities. Interested parties should monitor SAM.gov for the solicitation, expected to be issued around December 15, 2025, with a closing date of December 30, 2025, and may direct inquiries to Chris Carthron at Christopher.Carthron@va.gov.
    6505--LANSOPRAZOLE
    Buyer not available
    The Department of Veterans Affairs is seeking to procure Lansoprazole, a pharmaceutical product, for the Tucson Consolidated Mail Outpatient Pharmacy (CMOP). This procurement is justified as a sole source requirement, indicating that Lansoprazole is essential for the pharmacy's operations and patient care. The drug falls under the category of drugs and biologicals, highlighting its critical role in treating various medical conditions. Interested vendors can reach out to Contract Specialist Brigitte Kidder at Brigitte.Kidder@va.gov or by phone at 913-946-0150 for further details regarding this opportunity.
    6550--HEMOCHRON SIGNATURE ELITE REAGENTS BASE PLUS 4 OPTION YEARS
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of Hemochron Signature Elite Reagents, with a contract that includes a base year and four option years, extending from January 1, 2026, to December 31, 2030. The Southern Arizona VA Health Care System requires these reagents for quality control materials, supplies, and consumables compatible with existing Hemochron Signature Elite Instruments, all of which must be FDA-approved and delivered within specified timeframes. This procurement is critical for maintaining the efficiency and accuracy of patient testing at the Tucson facility. Interested vendors must submit their quotations electronically to Contract Specialist Rebecca Gaba at Rebecca.Gaba@va.gov by December 9, 2025, and are encouraged to address any questions by November 28, 2025.
    DA01--550-26-1-985-0034 InstyMed Dispenser System (VA-26-00024776)
    Buyer not available
    The Department of Veterans Affairs (VA) intends to negotiate a limited source contract for the InstyMed Dispenser System, identified by Solicitation Number 36C25226Q0106. This procurement includes the purchase of the dispenser system and professional installation services, emphasizing that it is not a request for proposal or quote, as no solicitation document is available. The InstyMed Dispenser System is crucial for enhancing medication delivery and management within VA facilities. Interested parties must respond to this notice by December 12, 2025, at 10:00 am CST, and can contact Contracting Officer Vernise L. Newton at vernise.newton@va.gov or by phone at 414-844-4850 for further information.
    6505--Positron Emission Tomography (PET) Radiopharmaceuticals for the Albany VA Medical Center
    Buyer not available
    The Department of Veterans Affairs is seeking qualified contractors to provide Positron Emission Tomography (PET) Radiopharmaceuticals for the Albany VA Medical Center. This procurement is structured as a five-year, firm fixed-price, Indefinite Delivery, Indefinite Requirements (IDIQ) contract, which includes a 12-month base period and four 12-month option periods. The required radiopharmaceuticals include F18 FDG Fluorodeoxyglucose, F18 NaF Sodium Fluoride, Pylarify (piflufolastat F18), Neuroceq (florbetaben F18), and Flyrcado (flurpiridaz F18), all essential for patient care in the Nuclear Medicine Department. Interested contractors must be licensed by the United States Nuclear Regulatory Commission (NRC) and the Food and Drug Administration (FDA) to manufacture and distribute these products in New York State, with responses due by 12:00 PM Eastern Standard Time on December 8, 2025. For further inquiries, contractors can contact Jonathan Kilgore, the Contracting Officer, at jonathan.kilgore@va.gov or by phone at 973-676-1000.